University of Miami
Coral Gables, Florida, 33146, United States
NCT Number: NCT06582927
The present study evaluates the efficacy of Mindfulness-Based Attention Training on measures targeting cognitive abilities and emotional well-being in first responders.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Coral Gables, Florida, 33146, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MBAT is an evidence-based 8-hour mindfulness program that comprises 4 central topics and associated practices. The concentration topic introduces participants to mindfulness "basics," including discussion of focused attention and mind wandering. The body awareness theme involves the cultivation of greater self-awareness, and the development of equanimity. The open monitoring theme emphasizes awareness of and receptivity to changing experiences and moments of uncertainty. The theme of connection addresses leadership and group cohesion, and the cultivation of kindness and connection with others.
The course content and materials in the present study will entail the foundational MBAT curriculum and other related content delivered virtually over Zoom but will consist of 8, 1-hour sessions delivered across 8 consecutive weeks.
Time frame: Baseline to week 11
The Sustained Attention to Response Task (SART) is used to assess attentional performance and mind wandering (i.e., off-task thinking which is typically self-generated and compromises the performance of the task at hand). The task uses a continuous performance paradigm involving button presses to frequently presented nontargets (numbers 0, 1, 2, 4, 5, 6, 7, 8, and 9) but requires the participants to withhold their motor response to the infrequent target (number 3). Withholding responses only to infrequent targets encourages a pre-potent response and mind wandering. Real-time subjective experience of mind wandering during SART is assessed through experience-sampling probes randomly presented throughout the task.
Time frame: Baseline to week 11
Resilience is assessed via the 6-item Brief Resilience Scale (BRS). The scores range from 6 to 30, with a higher score indicating a higher level of resilience.
Time frame: Baseline to week 11
Decentering is assessed via the 11-item decentering sub-scale of the experience questionnaire (EQ-D). The decentering score ranges from 1 to 55, with a higher score indicating a higher level of decentering.
Time frame: Baseline to week 11
Positive Affect is assessed with the 5-item positive sub-scale from Positive and Negative Affect Schedule (PANAS). PANAS Positive has a range of scores from 5 to 25, with a higher score indicating a higher positive mood.
Time frame: Baseline to week 11
Negative Affect is assessed with the 5-item negative sub-scale from Positive and Negative Affect Schedule (PANAS-10). PANAS Negative has a range of scores from 5 to 25, with a higher score indicating a higher negative mood.
Time frame: Baseline to week 11
Perceived stress is assessed with the 4-item Perceived Stress Scale (PSS-4). PSS-4 has a range of scores from 0 to 16, with a higher score indicating a higher level of perceived stress.
Time frame: Baseline to week 11
Burnout is assessed with the 12-item Burnout Assessment Tool (BAT-12). BAT-12 has a range of score from 1 to 5, with a higher score indicated a higher level of burnout.
University of Miami
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07342673
Behavior, Behavioral Symptoms
Winston-Salem, North Carolina, United States
View Trial DetailsNCT07720297
Behavior, Behavioral Symptoms
Columbus, Ohio, United States
View Trial DetailsNCT06085105
Adverse Outcomes, Behavior
Navrongo, Ghana
View Trial DetailsNCT06244784
Behavior, Behavioral Symptoms
Granollers, Barcelona, Spain
View Trial Details